Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
The Journal of Infection|July 18, 2026
Serological outcomes of SARS-CoV-2 infection by vaccination status and variant in EnglandCatherine Quinot, Rachel Lunt, Freja Kirsebom, et al.
Nature Communications|December 11, 2021
Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in EnglandGayatri Amirthalingam, Jamie Lopez Bernal, Nick J Andrews, et al.
Plos One|October 29, 2015
Risk of Injection-Site Abscess among Infants Receiving a Preservative-Free, Two-Dose Vial Formulation of Pneumococcal Conjugate Vaccine in KenyaDeron C Burton, Godfrey M Bigogo, Allan O Audi, et al.
The Lancet. Healthy Longevity|December 7, 2021
Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in EnglandAnna Jeffery-Smith, Thomas A J Rowland, Monika Patel, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 20, 2026
Influenza vaccine effectiveness from nine studies during drifted A(H3N2) subclade K predominance, Europe, September 2025 to January 2026Heloise Lucaccioni, Diogo Fp Marques, Freja Kirsebom, et al.
The Journal of Infection|April 11, 2022
Sociodemographic disparities in COVID-19 seroprevalence across England in the Oxford RCGP primary care sentinel networkHeather Whitaker, Ruby S M Tsang, Elizabeth Button, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 21, 2025
Interim 2024/25 influenza vaccine effectiveness: eight European studies, September 2024 to January 2025Angela Mc Rose, Héloïse Lucaccioni, Kimberly Marsh, et al.
Vaccine|November 6, 2019
End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19Richard G Pebody, Heather Whitaker, Joanna Ellis, et al.
Microbiology Spectrum|February 24, 2022
Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom's COVID-19 Public Health ResponseAshley David Otter, Abbie Bown, Silvia D'Arcangelo, et al.
Influenza and Other Respiratory Viruses|May 22, 2024
Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United KingdomHeather Whitaker, Beth Findlay, Jana Zitha, et al.
Pageof 9